NEW YORK (GenomeWeb) – Sequenom said today that it has secured in-network contracts with Blue Cross and Blue Shield of Georgia, as well as Anthem Blue Cross and Blue Shield plans for Indiana, Kentucky, Missouri, Ohio, Wisconsin, and Virginia.
The agreements provide in-network coverage for Sequenom's noninvasive prenatal tests for high-risk and average-risk pregnancies. The Georgia agreement does not include HMO plans and the Virginia agreement does not include HealthKeepers products.
"Becoming an in-network provider with leading health insurers, particularly for average-risk pregnancies, is a critical component of our commercialization plan," Sequenom CEO and President Dirk van den Boom said in a statement.
The molecular diagnostic company originally inked a five-year agreement with the Blue Cross Blue Shield Association in 2013 to offer its testing services to the independent companies. However, the firm still had to negotiate in-network status with each of the 36 independent providers within the association.
In March, it signed agreements with Anthem Blue Cross and Blue Shield in Connecticut, Maine, and New Hampshire to provide coverage for NIPT for both high- and average-risk pregnancies.